Pregnancy Clinical Trial
Official title:
A Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Women With Threatened Miscarriage in the First Trimester
NCT number | NCT02128685 |
Other study ID # | UW 13-292 |
Secondary ID | |
Status | Completed |
Phase | Phase 3 |
First received | |
Last updated | |
Start date | March 2016 |
Est. completion date | May 31, 2018 |
Verified date | October 2018 |
Source | The University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to determine whether the dydrogesterone therapy is associated with reduction in miscarriage in women with first trimester threatened miscarriage. The hypothesis is that the dydrogesterone therapy will significantly reduce the risk of miscarriage in women with threatened miscarriage.
Status | Completed |
Enrollment | 406 |
Est. completion date | May 31, 2018 |
Est. primary completion date | May 31, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Age of women from 18-40 years at the time of recruitment (not beyond 40th birthday) - Absence of fever - Gestation less than 12 completed weeks as defined by pelvic ultrasound - Presence of intrauterine gestational sac(s) if an urine pregnancy test is first positive within past 2 weeks - Presence of intrauterine fetus(es) with crown-rump length of <7mm and no fetal pulsation, or presence of intrauterine fetus(es) with positive fetal heart pulsation confirmed on pelvic scanning Exclusion Criteria: - Age of women >40 years at the time of recruitment - History of recurrent miscarriage defined as at least three consecutive spontaneous miscarriages - History of known parental chromosomal abnormalities - Heavy vaginal bleeding requiring surgical intervention - Severe abdominal pain requiring surgical intervention - Absence of cardiac pulsation in a fetal pole with crown-rump length of >=7mm on transvaginal scanning - Use of hCG or progesterone treatment for threatened miscarriage prior to recruitment |
Country | Name | City | State |
---|---|---|---|
Hong Kong | Department of Obstetrics and Gynaecology, PYNEH | Chai Wan | |
Hong Kong | Department of Obstetrics & Gynaecology, Queen Mary Hospital | Hong Kong | |
Hong Kong | Department of Obstetrics & Gynaecology, Kwong Wah Hospital | Mong Kok |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong |
Hong Kong,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The chance of miscarriage before 20 weeks of gestation | At 20 weeks of gestation | ||
Secondary | Live birth rate | At the time of delivery, from 24 weeks of gestation till term gestation | ||
Secondary | The proportion of heavy vaginal bleeding or severe abdominal pain requiring surgical intervention (<20 weeks) | Before 20 weeks of gestation | ||
Secondary | The incidence of antepartum hemorrhage | Any vaginal bleeding during pregnancy from the 24th week gestational age to term | From 24 weeks of gestation till term | |
Secondary | The incidence of placenta previa | Placenta is being inserted partially or wholly in the lower uterine segment and will be diagnosed by antenatal ultrasound at second and third trimesters | From 24 weeks of gestation till term | |
Secondary | The incidence of pregnancy-induced hypertension | Any development of newly-onset hypertension (blood pressure persistently >=140/90mmHg on two occasions at least 4 hours apart) during pregnancy after 20 weeks gestation, labour or the puerperium in a previously normotensive non-proteinuric women | From 20 weeks of gestation till term | |
Secondary | The incidence of intrauterine death | Fetus dies in uterus after 24 weeks gestation | After 24 weeks of gestation till term | |
Secondary | The incidence of preterm labour | Any premature spontaneous delivery from 24 weeks to 36 weeks gestation | From 24 weeks to 36 weeks gestation | |
Secondary | Low birth weight at term (grams) | Baby born with birth weight less than 2500g at or after 37 weeks gestation | After 37 weeks gestation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |